AGENUS INC — Investor Relations & Filings
Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46361646 | 8-K | 2026-05-15 | English | ||
| 45001328 | 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 44960365 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 39218368 | DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | ||
| 33051679 | SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | ||
| 33048504 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English | ||
| 32887479 | 4 - AGENUS INC (0001098972) (Filer) | 2026-02-24 | English | ||
| 27360653 | 4 Filing | 2026-02-09 | English | ||
| 27360005 | 4 Filing | 2026-01-26 | English | ||
| 27360607 | SCHEDULE 13D Filing | 2026-01-23 | English | ||
| 27360811 | 8-K Filing | 2026-01-16 | English | ||
| 27360755 | 3 Filing | 2026-01-16 | English | ||
| 27359870 | 8-K Filing | 2026-01-14 | English | ||
| 27360545 | 4 Filing | 2026-01-12 | English | ||
| 27359929 | 8-K Filing | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
AGENUS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34023/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34023 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34023 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34023 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34023}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AGENUS INC (id: 34023)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.